rol del sistema nervioso renal en la hipertensión refractaria
TRANSCRIPT
Rol del sistema nervioso renal en la
hipertensión refractaria
Dr Ramiro Sanchez
Jefe de Hipertension Arterial y Unidad Metabolica Fundacion Favaloro
¿Daño de órgano blanco?
– Cardiopatía– Nefropatía– Neuropatía– Vasculopatía
Comorbilidades
– Tabaquismo– Alcoholismo– Obesidad– Ansiedad– Sedentarismo– Diabetes
Adherencia
Monitoreo constante
Sal
Sodio en
orina24 hs
Secundaria
Investigación de acuerdo a las Guías de Hipertensión
Hipertensión Resistente
Sospecha de Hipertensión Resistente
Descartar pseudoresistencia– Adherencia a tratamiento farmacológico y
no farmacológico– Dosis inadecuada
Descartar efecto de guardapolvo blanco(MAPA24hs)
Nervios Aferentes Renales
The kidney is a source of central sympathetic activity, sending signals to the CNS
Nervios Eferentes Renales
Sympathetic signals from the CNS modulate the physiology of the
kidneys
Inervacion Renal y su conexion con el SNC
Adapted from Schlaich MP, et al. Hypertension. 2009;54:1195-1201.
Blood Pressure Neurohormones
GFRIschemia
Kidney FailureWorsening Kidney Failure
Smooth Muscle Migration
VasoconstrictionAtherosclerosis
Efectos Cardiorenales de la Activación Crónica del
Sistema Nervioso Simpático
Adapted from Schlaich MP, et al. Hypertension. 2009;54:1195-1201.
HypertrophyIschemia
ArrhythmiaHeart Failure
Worsening HF
S Julius, R Sanchez, et al, Hypertension, Vol.4, 782, 1982
Car
dia
c outp
ut
(pro
po
rtio
n o
f co
ntr
ol)
Tota
l per
ipher
al r
esis
tance
(pro
po
rtio
n o
f co
ntr
ol)
1.10
1.00
0.90
0.80
1.80
1.60
1.40
1.20
1.00
-10 10 20 30 400 -10 10 20 30 400
Ganglionic Blockade
**
**
† †
Time (min)
Ganglionic blockade
L. b. compressionLower b. compression
Effects of increased renal sympathetic nerve activity (RSNA) on the 3 renal neuroeffectors: the juxtaglomerular granular cells (JGGC) with increased RSR via stimulation of β-1 adrenoceptors
(β-1-AR), the renal tubular epithelial cells (T) with increased ren...
DiBona G F , and Esler M Am J Physiol Regul Integr Comp Physiol 2010;298:R245-R253
©2010 by American Physiological Society
The relationship between renal nerve stimulation (RNS) frequency and maximum response of renin secretion rate (RSR) (increase), urinary sodium excretion (decrease) and renal blood flow
(RBF) (decrease). [From DiBona GF (10a).].
DiBona G F , and Esler M Am J Physiol Regul Integr Comp Physiol 2010;298:R245-R253
©2010 by American Physiological Society
Influence of renal nerves on relationship between urinary flow rate (%H2O excretion) or urinary sodium excretion (%Na excretion) and renal perfusion pressure (RPP).
DiBona G F , and Esler M Am J Physiol Regul Integr Comp Physiol 2010;298:R245-R253
©2010 by American Physiological Society
Effect of TRPV1 stimulation by capsaicin, either given intrarenally (IRA Cap; n=10) or systemically (IV Cap; n=10).
Ditting T et al. Hypertension 2012;59:467-476
Copyright © American Heart Association
Tonic Postganglionic Sympathetic Inhibition Induced by
Afferent Renal Nerves? Tilmann Ditting, et al.Hypertension. 2012;59:467-476
• RSNA is increased, whereas its control is impaired in arterial hypertension
• The study indicates a direct evidence that afferent intrarenal nerves provide a tonically acting sympathoinhibitory system, which seems to be rather mediated by neurokinin release acting via neurokinin 1 receptor pathways rather than by electric afferent effects on central sympathetic outflow.
Figure 5. Plasma renin activity (upper panel) and plasma concentrations of angiotensin II (middle panel) and aldosterone (lower panel) in the supine position and after 30 minutes of
45° head-up tilt (HUT) with placebo (○) and reboxetine (•). n=10, #P<0.08; ...
Mayer A F et al. Hypertension 2006;48:120-126
Copyright © American Heart Association
Figure 2. RBF and renal vascular resistance in the supine position after ingestion of 8 mg reboxetine (•, drawn line) or placebo (○, dotted line). n=16, *P<0.05 (paired t test).
Mayer A F et al. Hypertension 2006;48:120-126
Copyright © American Heart Association
The “gold standard” electrophysiological and neurochemical methods for studying the human sympathetic nervous system are multiunit postganglionic efferent sympathetic
nerve recording and isotope dilution measurement of norepinephrine release to plasma.
Esler M J Appl Physiol 2010;108:227-237
©2010 by American Physiological Society
Grassi G Hypertension 2009;54:690-697
Copyright © American Heart Association
Figure 2. Behavior of muscle sympathetic nerve traffic (MSNA), expressed as bursts incidence corrected for heart rate (bs/100 hb) in mild-to-moderate (MEH) and severe (SEH) hypertension (left panel), in white coat (WCHT) and masked (MHT) hypertension (centr...
Grassi G Hypertension 2009;54:690-697
Copyright © American Heart Association
17
J Hypertens 24:789-801;2006
H y p e r l e p t i n e m i a
A r t e r i a l h y p e r t e n s i o n
Vasoconstriction Na+ retention
Renal Na+, K+ -ATPase
NO
Oxidative stressSNS
For
dis
trib
utio
n o
nly
in m
ark
ets
where
the S
ymplic
ity
TM
ren
al denerv
ation
sys
tem
is a
ppro
ved.
Sym
plic
ity
is a
tra
dem
ark
of M
edtr
on
ic, In
c. a
nd
is
reg
iste
red in
one o
r m
ore
countr
ies o
f th
e w
orld. N
ot fo
r dis
trib
ution in
the U
SA
or
Japan. ©
2012 M
edtr
onic
, In
c. A
ll rights
reserv
ed
. M
KG
02
5
3/1
2
Desnervacion Renal
Blood Pressure Neurohormones
Disrupt the renal nerves,break the cycle
Simultaneously reduce bothefferent & afferent effects
Adapted from Schlaich MP, et al. Hypertension. 2009;54:1195-1201.
For
dis
trib
utio
n o
nly
in m
ark
ets
where
the S
ymplic
ity
TM
ren
al denerv
ation
sys
tem
is a
ppro
ved.
Sym
plic
ity
is a
tra
dem
ark
of M
edtr
on
ic, In
c. a
nd
is
reg
iste
red in
one o
r m
ore
countr
ies o
f th
e w
orld. N
ot fo
r dis
trib
ution in
the U
SA
or
Japan. ©
2012 M
edtr
onic
, In
c. A
ll rights
reserv
ed
. M
KG
02
5
3/1
2
Baseline
1 Month
12 Months
MSNA
(burst/min)
BP
(mm Hg)
56 161/107
41 141/90 (-20/-17)
19 127/81 (-34/-26)
Improvement in cardiac baroreflex sensitivity after renal denervation (7.8 11.7 msec/mm Hg)
Reduced Sympathetic Nerve Activity After
Catheter-Based Renal Denervation*
New Engl J Med Case Study
*59-year-old male on antihypertensive medications.Schlaich MP, et al. New Engl J Med. 2009;361:932-934.
For
dis
trib
utio
n o
nly
in m
ark
ets
where
the S
ymplic
ity
TM
ren
al denerv
ation
sys
tem
is a
ppro
ved.
Sym
plic
ity
is a
tra
dem
ark
of M
edtr
on
ic, In
c. a
nd
is
reg
iste
red in
one o
r m
ore
countr
ies o
f th
e w
orld. N
ot fo
r dis
trib
ution in
the U
SA
or
Japan. ©
2012 M
edtr
onic
, In
c. A
ll rights
reserv
ed
. M
KG
02
5
3/1
2
Baseline 1 Month ∆
Office BP (mm Hg) 161/107 141/90
Renal NE spillover (ng/min)
• Left kidney 72 37 -48%
• Right kidney 79 20 -75%
Total body NE spillover (ng/min) 600 348 -42%
Plasma renin (μg/l/hr) 0.3 0.15 -50%
Renal plasma flow (mL/min) 719 1126 57%
Left ventricular mass (g/m2) 78.8 73.1 -7%
Changes in Underlying Physiology
Consistent With Renal Denervation*
New Engl J Med Case Study
*59-year-old male on antihypertensive medications.Schlaich MP, et al. New Engl J Med. 2009;361:932-934.
Proportion of patients with normal urinary albumin excretion (UAE), microalbuminuria (MAU), and macroalbuminuria at baseline and 3 and 6 months after renal denervation.
Mahfoud F et al. Hypertension 2012;60:419-424
Copyright © American Heart Association
For
dis
trib
utio
n o
nly
in m
ark
ets
where
the S
ymplic
ity
TM
renal de
nerv
ation s
yste
m is a
ppro
ved. S
ymplic
ity
is a
tra
dem
ark
of M
edtr
on
ic, In
c. a
nd
is
reg
iste
red in
one o
r m
ore
countr
ies o
f th
e w
orld. N
ot fo
r dis
trib
ution in
the U
SA
or
Japan. ©
2012 M
edtr
onic
, In
c. A
ll rights
reserv
ed
. M
KG
02
5
3/1
2
• No change in renal function
Symplicity HTN-2 Trial –
Chronic Safety (cont)
∆ Renal Function
(baseline-6M)
Symplicity
Renal
Denervation
Group
Control
Group
Difference
(95% CI) P-value
Mean eGFR ± SD
(mL/min/1.73m2)
0.2 ± 11
(n=49)
0.9 ± 12
(n=51)
-0.7
(-5.4, 3.9)0.76
Mean serum creatine ± SD
(μmol/L)
0.2 ± 17.6
(n=49)
-1.1 ±
10.3
(n=51)
1.3
(-4.5, 7.0)0.67
Mean cystatin-C ± SD
(mg/L)
0.1 ± 0.2
(n=37)
0.0 ± 0.1
(n=40)
0.0
(0.0, 0.1)0.31
Symplicity HTN-2 Investigators. Lancet. 2010;376:1903-1909.
Sympathetic Nervous System and Hypertension, Gerald F. DiBona Hypertension. 2013;61:556-560
Luego de la desnervación renal la actividad SNS aferente y eferente renal disminuye. El descenso de la actividad eferente hacia el riñón se traduce en reducción del sistema RAA renal, reducción de la resistencia vascular renal, incremeneto del flujo sanguineo renal y reducción de la reabsorción de sodio, con normalización de la curva de natriuresis por presión. Todas estas condiciones favorecen el descenso de la presión arterial. Los efectos de la reducción de la actividad aferente desde el riñón se traduce en un descenso de la actividad simpática periférica, descenso de las resistencias vasculares periféricas y del volúmen minuto cardíaco y una posterior reducción de la actividad simpatica sobre el riñón.
ConclusionesEl sistema nervioso simpático aferente renal participa en la regulación del tono vasomotor renal y la homeostasis del sodio
El sistema nervioso eferente renal participa en la regulación de la presión arterial, función cardiovascular y regulación del metabolismo hidrocarbonado
El sistema nervioso renal es uno de los factores que contribuyen a la severidad de la hipertensión arterial en la hipertensión resistente
La desnervación renal puede contribuir eficazmente en el tratamiento de la hipertensión resistente
Figure Digital subtraction angiography Showing (August, 2011) renal denervation at a superior position (position 5 of 6) near the
ostium; and (February, 2012) ostial stenosis and blood pressure gradient across the stenosis.
Oliver Vonend , Gerald Antoch , Lars Christian Rump , Dirk Blondin
Secondary rise in blood pressure after renal denervation
The Lancet Volume 380, Issue 9843 2012 778
http://dx.doi.org/10.1016/S0140-6736(12)61145-3